RNA Target: RNU6-1118P (G106480058)

Target Name: RNU6-1118P

NCBI ID: G106480058

RNU6-1118P

Other Name(s): RNA, U6 small nuclear 1118, pseudogene

RNA Target: RNU6-1118P

RNA, U6 small nuclear 1118, pseudogene (RNU6-1118P) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a 19-nt RNA molecule that is expressed in all cell types and is highly conserved across different organisms.

RNU6-1118P is a pseudogene, which means that it is a non-coding RNA molecule that has been preserved from gene expression, but it still has the potential to encode a protein. The conservation of RNU6-1118P across different organisms suggests that it may have been involved in the evolution of early life forms.

RNU6-1118P has been shown to play a role in various cellular processes. For example, it has been shown to be involved in cell signaling, DNA replication, and transcription. It has also been shown to interact with various protein molecules, including the protein encoded by the gene SNAPK.

One of the potential reasons why RNU6-1118P is being targeted as a drug or biomarker is its role in cancer. Cancer is a disease that is characterized by the uncontrolled growth and spread of cells. RNU6-1118P has been shown to promote the growth and survival of various cancer cell types.

In addition to its role in cancer, RNU6-1118P has also been shown to be involved in the development of neurodegenerative diseases. Neurodegenerative diseases are characterized by the progressive loss of brain cells and the development of various neurological symptoms.

RNU6-1118P has been shown to be involved in the development of neurodegenerative diseases by promoting the production of pro-inflammatory molecules. These molecules can cause the immune system to react in an unfavorable way, leading to the progressive loss of brain cells.

In conclusion, RNU6-1118P is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its role in various cellular processes and its potential involvement in cancer and neurodegenerative diseases make it an interesting target for further research. Further studies are needed to determine the full potential of RNU6-1118P as a drug or biomarker.

Protein Name: RNA, U6 Small Nuclear 1118, Pseudogene

The "RNU6-1118P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-1118P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets